These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24470170)

  • 1. Functional characterization of cynomolgus monkey UDP-glucuronosyltransferase 1A9.
    Yamamoto K; Mukai M; Nagaoka K; Hayashi K; Hichiya H; Okada K; Murata M; Shigeyama M; Narimatsu S; Hanioka N
    Eur J Drug Metab Pharmacokinet; 2014 Sep; 39(3):195-202. PubMed ID: 24470170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A6 enzymes.
    Hanioka N; Takeda Y; Jinno H; Tanaka-Kagawa T; Naito S; Koeda A; Shimizu T; Nomura M; Narimatsu S
    Chem Biol Interact; 2006 Dec; 164(1-2):136-45. PubMed ID: 17027947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A1 enzymes.
    Hanioka N; Tanabe N; Jinno H; Tanaka-Kagawa T; Nagaoka K; Naito S; Koeda A; Narimatsu S
    Life Sci; 2010 Aug; 87(7-8):261-8. PubMed ID: 20620155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro glucuronidation of propofol in microsomal fractions from human liver, intestine and kidney: tissue distribution and physiological role of UGT1A9.
    Mukai M; Tanaka S; Yamamoto K; Murata M; Okada K; Isobe T; Shigeyama M; Hichiya H; Hanioka N
    Pharmazie; 2014 Nov; 69(11):829-32. PubMed ID: 25985579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective glucuronidation of propranolol in human and cynomolgus monkey liver microsomes: role of human hepatic UDP-glucuronosyltransferase isoforms, UGT1A9, UGT2B4 and UGT2B7.
    Hanioka N; Hayashi K; Shimizudani T; Nagaoka K; Koeda A; Naito S; Narimatsu S
    Pharmacology; 2008; 82(4):293-303. PubMed ID: 18936551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
    Rowland A; Knights KM; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution.
    Kato Y; Nakajima M; Oda S; Fukami T; Yokoi T
    Drug Metab Dispos; 2012 Feb; 40(2):240-8. PubMed ID: 22028316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of N-glucuronidation of 4-(5-pyridin-4-yl-1H-[1,2,4]triazol-3-yl) pyridine-2-carbonitrile (FYX-051): a new xanthine oxidoreductase inhibitor.
    Omura K; Nakazawa T; Sato T; Iwanaga T; Nagata O
    Drug Metab Dispos; 2007 Dec; 35(12):2143-8. PubMed ID: 17761779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro glucuronidation of Armillarisin A: UDP-glucuronosyltransferase 1A9 acts as a major contributor and significant species differences.
    Sun D; Zhu L; Xiao L; Xia Y; Ge G; Cao Y; Wu Y; Yin J; Yang L
    Xenobiotica; 2014 Nov; 44(11):988-95. PubMed ID: 24916899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of afloqualone N-glucuronidation: species differences and identification of human UDP-glucuronosyltransferase isoform(s).
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Jan; 33(1):60-7. PubMed ID: 15475412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and functional characterization of UDP-glucuronosyltransferase 1A in cynomolgus macaques.
    Uno Y; Takahira R; Murayama N; Ishii Y; Ikenaka Y; Ishizuka M; Yamazaki H; Ikushiro S
    Biochem Pharmacol; 2018 Sep; 155():172-181. PubMed ID: 29944869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species and sex differences in propofol glucuronidation in liver microsomes of humans, monkeys, rats and mice.
    Mukai M; Isobe T; Okada K; Murata M; Shigeyama M; Hanioka N
    Pharmazie; 2015 Jul; 70(7):466-70. PubMed ID: 26373207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10.
    Watanabe Y; Nakajima M; Yokoi T
    Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
    Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
    Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9.
    Kishi N; Takasuka A; Kokawa Y; Isobe T; Taguchi M; Shigeyama M; Murata M; Suno M; Hanioka N
    Xenobiotica; 2016; 46(4):289-95. PubMed ID: 26247833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
    Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
    Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
    Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
    Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amino acid substitutions at positions 33 and 37 on UDP-glucuronosyltransferase 1A9 (UGT1A9) activity and substrate selectivity.
    Korprasertthaworn P; Rowland A; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
    Biochem Pharmacol; 2012 Dec; 84(11):1511-21. PubMed ID: 22981363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.